Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Cadila in talks to acquire Biochem Pharmaceuticals’ brands and facility

>>

Cadila Healthcare’s Q1 consolidated net profit registers 15% growth

>>

Cadila Healthcare to raise upto Rs 150 crore via bonds

>>

Cadila Healthcare receives USFDA warning for manufacturing violations

>>

Cadila Healthcare's US arm to acquire assets of Nesher Pharmaceuticals

>>

Cadila Pharma spreads wings to Rwanda

>>

Cadila launches Parkinson's generic drug in the US market

<< < 166 167 168 > >>